| Document |
Document Title |
|
WO/2016/193740A1 |
The invention relates to a process for the preparation of one or more intermediate chemical compounds useful in the preparation of non-ionic contrast agents wherein the process is carried out continuously using one or more flow procedures.
|
|
WO/2016/193190A1 |
The present invention relates to a new class of high relaxivity extracellular gadolinium chelate complexes, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents.
|
|
WO/2016/194586A1 |
A radioactively labeled compound production device (100) is a production device for producing a radioactively labeled compound by introducing a radioactive isotope into a non-radioactively labeled precursor compound. The production devic...
|
|
WO/2016/187718A1 |
A controlled extended release composition comprising at least one unit dosage form having at least one active pharmaceutical ingredient (API), wherein said at least one API comprises at least one of pregabalin, a base thereof, a pharmace...
|
|
WO/2016/186838A1 |
The present invention is directed to energy curable inkjet inks or coating compositions, comprising Michael addition reaction products of primary and secondary alkanolamines with stoichiometric excesses of polyacrylates. Furthermore the ...
|
|
WO/2016/179692A1 |
The present disclosure provides a process for preparing iminodisuccinic acid salts using maleic anhydride, aspartic acid, and a base in water. In an example, maleic anhydride and aspartic acid are mixed with a base to form a slurry, pref...
|
|
WO/2016/180664A1 |
Process for making a chelating agent according to the general formula (I), R1-CH(COOX1)-N(CH2COOX1)2 wherein R1 is selected from hydrogen, C1-C4-alkyl, phenyl, benzyl, CH2OH, and CH2CH2COOX1, X1 is (ΜχΗ1-χ), M being selected from alk...
|
|
WO/2016/179213A1 |
An energy curable ink for use in the production of layered composites the ink comprising 3 to 50% by weight of aminoacrylate, 5 to 60% by weight of hydroxyl functional acrylate monomer and wherein the non-volatile content of the ink is n...
|
|
WO/2016/176771A1 |
The present description relates to an anti-aging composition comprising at least one plant extract. The composition can comprise at least two different anti-aging agents, wherein one the anti-aging agent is a plant extract. The combinati...
|
|
WO/2016/176691A1 |
Methods for determining renal function in an animal subject, the method including measuring the concentration of β-aminoisobutyric acid (β-amino isobutyrate) (BAIB) in patients samples and determining the presence, likelihood, or progr...
|
|
WO/2016/173960A1 |
The invention relates to an optimized synthesis of pregabalin and additional 4-aminobutane acids using an improved method for producing conjugated nitroalkenes. This is achieved by a nitro-aldol reaction of an aliphatic aldehyde with a n...
|
|
WO/2016/171240A1 |
The present invention addresses the problem of providing an excellent method for producing an excellent therapeutic agent. The solution of the present invention is as shown in the following scheme. (In the formulae, R1 represents a C1-C6...
|
|
WO/2016/167258A1 |
Provided is an adsorbent for odorants, the adsorbent containing a hydrazine compound (a) and at least one compound (b) selected from the group consisting of amine compounds (b1) represented by a specific general formula or salts thereof,...
|
|
WO/2016/168118A1 |
Novel compounds of formula (II) are disclosed. Compounds of formula (II) comprise ornithine derivatives or compounds that may metabolize to ornithine. Also disclosed are methods for the treatment of neurodegenerative diseases such as Alz...
|
|
WO/2016/163757A1 |
The present invention relates to a nanoparticle for detecting an antiviral agent-resistant virus. The present invention enables fast and convenient diagnosis/detection, with the naked eyes, of an Oseltamivir (Tamiflu)-sensitive/resistant...
|
|
WO/2016/164748A1 |
This document describes a process for the high purity and high concentration recovery of monovalent products via continuous ion exchange from aqueous solution for further downstream purification.
|
|
WO/2016/164767A1 |
The present disclosure relates to methods for separating at least one amine chosen from diamines and omega-aminoacids from a feed mixture using a simulated moving bed (SMB) adsorptive technology.
|
|
WO/2016/161921A1 |
Conjugate compounds having at least one of a moiety derived from ursodeoxycholic acid, or eicosapentaenoic acid, or docosahexaenoic acid, or rhein, or R- (+) -α-lipoic acid, or ursolic acid, or corosolic acid, or hydroxycitric acid, or ...
|
|
WO/2016/155888A1 |
The present invention relates to novel compounds of the formula I, methods for their preparation and their use for treatment of diseases. The invention discloses the synthesis of levodopa (L-DOPA) esters by coupling polyhydroxy compounds...
|
|
WO/2016/154730A1 |
A method of treating high blood glucose levels is disclosed. The method includes administering gut anti-inflammatory agents such as mesalamine (5-aminosalicylic acid), sulfasalazine, asacol, delzicol, pentasa, lialda, apriso, olsalazine,...
|
|
WO/2016/161269A1 |
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, vi...
|
|
WO/2016/155596A1 |
Disclosed is a method of synthesizing a 3-halo-D-alanine methyl ester or an acid salt thereof. By reacting a D-serine methyl ester or an acid salt thereof and a halogenation reagent in an organic solvent, the method prepares a 3-halo-D-a...
|
|
WO/2016/153064A1 |
[Problem] To provide a novel diamine for imparting a thin film that has not only exceptional flexibility and transparency, but also low retardation. [Solution] Provided are: a diamine characterized by being represented by formula (1-1); ...
|
|
WO/2016/151990A1 |
The present invention relates to novel tertiary alcohol derivatives substituted with aryl and trifluoromethyl, and optical isomers thereof. In addition, the present invention also relates to methods for the preparation and use as enantio...
|
|
WO/2016/150953A1 |
The present invention relates to a process for synthesis of 4,5,6,7- tetrahydroisoxazolo[5,4-c]pyridin-3-ol abbreviated THIP, having the INN name gaboxadol, starting from pyrrolidin-2-one. The process comprises a new direct process to ob...
|
|
WO/2016/142220A1 |
The present invention is directed towards mixtures comprising (A) 90 to 99.9 % by weight of a mixture of L- and D-enantiomers of methyl glycine diacetic acid (MGDA) or its respective mono-, di- or trialkali metal or mono-, di- or triammo...
|
|
WO/2016/142228A1 |
Process for preparation of a mixture of methyl glycine diacetic acid (MGDA) or its respective mono-, di-, trialkali metal salt or its respective mono-, di- or tri-ammonium salt or mixtures thereof, and glutamic acid diacetic acid (GLDA) ...
|
|
WO/2016/140104A1 |
The present invention provides a 3-phenylisoserine derivative production method for obtaining 3-phenylisoserine derivatives represented by formula (2) (in the formula, R1 represents a phenyl group or a phenyl group having a substituent g...
|
|
WO/2016/140799A1 |
Compounds and methods for use in detecting pregabalin in a sample suspected of containing pregabalin are disclosed. Pregabalin derivatives are described for producing pregabalin conjugates. A pregabalin-immunogenic carrier conjugate may ...
|
|
WO/2016/135397A1 |
The process for producing amino acids from volatile fatty acid (VFA) molecules, termed precursors, produced by anaerobic fermentation from fermentable biomass, comprises at least the following steps: - a) extracting the volatile fatty ac...
|
|
WO/2016/135151A1 |
The present invention relates to the fields of organic electronics and photonics. More particularly, the present invention relates to fluorescent charge-transfer compounds emitting in the visible spectral range from blue to red, comprisi...
|
|
WO/2016/133217A1 |
The present invention is able to provide a method for stereoselectively introducing an amino group having various substituents into the α-position of an oxindole compound by a single step by having a specific compound (a carbonyl compou...
|
|
WO/2016/128390A1 |
The present invention relates to amino alcohol compounds and to the preparation thereof from fatty esters comprising at least two carbon-carbon double bonds. In particular, the present invention relates to fatty amino alcohol compounds o...
|
|
WO/2016/129490A1 |
Provided is a polar compound having high chemical stability, high ability to align liquid crystal molecules, and high solubility in a liquid crystal composition, and which has a large voltage holding ratio when used in a liquid crystal d...
|
|
WO/2016/122802A1 |
This disclosure relates to picolinamides of Formula I and their use as fungicides. Fungicides are compounds, of natural or synthetic origin, which act to protect and/or cure plants against damage caused by agriculturally relevant fungi. ...
|
|
WO/2016/112875A2 |
The present invention relates to a diphenyl derivative and uses thereof, the diphenyl derivative having the structure as indicated in formula (I) defined in the description. The uses refer to the uses of the diphenyl derivative, pharmace...
|
|
WO/2016/110865A1 |
The invention relates to the compounds of formula I and II and its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compoun...
|
|
WO/2016/109501A1 |
The present invention is directed to amide compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment or prevention of diseases or disorders associated with peripheral ...
|
|
WO/2016/109300A1 |
The invention relates to picolinamides of Formula I and their use as fungicides.
|
|
WO/2016/103192A1 |
The present invention relates to peptides, and amino acid and peptide conjugates, methods for making amino acid and peptide conjugates, conjugates produced by the methods, pharmaceutical compositions comprising the peptides and conjugate...
|
|
WO/2016/104580A1 |
The invention provides a cationic lipid that can be utilized for nucleic acid delivery into the cytoplasm. This cationic lipid is, for example, a compound represented by formula (1) or a pharmaceutically acceptable salt thereof.
|
|
WO/2016/099465A1 |
Disclosed are salts, such as nitrates, of propionyl-L-carnitine and methods of making the compounds.
|
|
WO/2016/097026A1 |
Use of methyl glycine diacetic acid (MGDA) as additive in processes for recovering crude oil and/or gas from subterranean formations, wherein the MGDA is a mixture of L- and D-enantiomers of MGDA or salts thereof, said mixture containing...
|
|
WO/2016/091899A1 |
A fragrance precursor of (E/Z)-9-hydroxy-5,9-dimethyldec-4-enal, comprising at least an enamine and/or an aminal as reaction product of (E/Z)-9-hydroxy-5,9- dimethyldec-4-enal (compound according to formula (I)) and a primary and/or seco...
|
|
WO/2016/088082A1 |
The present invention provides a compound of formula (I): (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents an...
|
|
WO/2016/080033A1 |
This liquid crystal aligning agent is configured to contain a compound (X) that has a partial structure represented by formula (1). (In formula (1), each of R1 and R2 independently represents a hydrogen atom, a halogen atom, a cyano grou...
|
|
WO/2016/075082A1 |
The present invention relates to processes comprising a combined racemization and stereoselective reductive amination step in which an aldehyde compound of formula (I) is contacted with an (R)-selective ω-transaminase or an (S)-selectiv...
|
|
WO/2016/071249A1 |
The present invention relates to a novel method for producing substituted biphenylamines.
|
|
WO/2016/071485A1 |
The present invention relates to methods of labeling sugar moieties of sugar containing compounds including glycopeptides. The compounds presented in the present invention facilitate reliable detection of sugar moieties of sugar containi...
|
|
WO/2016/070257A1 |
The invention describes water-soluble iron (III) oxide-hydroxide complexes prepared from various sources of iron, amino acids and carboxylic acids, and pharmaceutical or food compositions containing same. The iron (III) complexes do not ...
|
